Grifols

Grifols EBIT per Share

The EBIT per Share of Grifols (GRF.MC) as of Sep 17, 2026 is 1.77 EUR. In the previous year, EBIT per Share was 1.68 EUR — a change of 5.41% (higher).

EBIT per Share

1.77EUR

YoY

5.41%

Last updated:

EBIT per Share of Grifols is 2026 1.77 EUR. EBIT per Share of Grifols was 2025 1.68 EUR. It decreases by 5.41% higher compared to the previous year.

The Grifols EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
1.09 EUR
Jan 1, 2024
1.68 EUR
Jan 1, 2025
1.77 EUR
Jan 1, 2026 (e)
1.98 EUR
Jan 1, 2027 (e)
2.29 EUR
Jan 1, 2028 (e)
2.59 EUR
Jan 1, 2029 (e)
2.96 EUR
Jan 1, 2030 (e)
3.18 EUR
The Grifols EBIT per Share history
YEAREBIT per ShareYoY
est3.18EUR+7.47%
est2.96EUR+14.18%
est2.59EUR+13.05%
est2.29EUR+15.88%
est1.98EUR+11.46%
1.77EUR+5.41%
1.68EUR+54.88%
1.09EUR-8.47%
1.19EUR+36.54%
0.87EUR-40.36%
1.46EUR-11.84%
1.65EUR+13.80%
1.45EUR+1.90%
1.43EUR+2.39%
1.39EUR-1.91%
1.42EUR+14.53%
1.24EUR+13.50%
1.09EUR+10.94%
0.98EUR+127.30%
0.43EUR-8.77%
0.47EUR+1.42%
0.47EUR+12.28%
0.42EUR+39.60%
0.30EUR+27.69%
0.23EUR—
Access this data via the Eulerpool API
Get Free API Key

Grifols Stock analysis

What does Grifols do? Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Grifols stock

EBIT per Share of Grifols is 1.77 EUR in 2026.

EBIT per Share of Grifols changed from 1.68 EUR to 1.77 EUR, representing a 5.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Grifols since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Grifols

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Grifols